R. van der Kant

A reference human induced pluripotent stem cell line for large-scale collaborative studies.

Sonja W. Scholz, M. Nalls, D. Vitale, 2022, Cell stem cell.

Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.

C. Iadecola, O. Chiba-Falek, J. Ulrich, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

K. Blennow, P. Scheltens, B. Dubois, 2021, Nature Reviews Neuroscience.

Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects

Rik van der Kant, F. Feringa, Femke M. Feringa, 2021, Frontiers in Aging Neuroscience.

Amyloid-β-independent regulators of tau pathology in Alzheimer disease

L. Goldstein, Rik van der Kant, R. Ossenkoppele, 2019, Nature Reviews Neuroscience.

A reference induced pluripotent stem cell line for large-scale collaborative studies

Sonja W. Scholz, M. Nalls, D. Vitale, 2021, bioRxiv.

The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4

M. Giera, Ricardo Miramontes, Christina E. Toomey, 2024, bioRxiv.

An inside job: New roles for ApoE at the lipid droplet

Femke M. Feringa, R. van der Kant, 2024, The Journal of cell biology.

APOE and immunity: Research highlights

Tyler J. Wishard, M. Carrillo, A. Brickman, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.